> The U.K.'s cost-effectiveness watchdog has issued preliminary draft guidance not recommending Celgene's ($CELG) multiple myeloma treatment Imnovid. More
> Sucampo and Takeda have extended their licensing agreement for constipation drug Amitiza. Release
> ViiV Healthcare has won approval for HIV pill Triumeq in Canada. Release
> Scotland has recommended Novartis' ($NVS) Gilenya for patients with a severe form of relapsing multiple sclerosis. Report
> Retrophin has agreed to divest ketamine, Syntocinon Nasal Spray, and Vecamyl to Turing Pharmaceuticals. Release
And Finally... Pfizer ($PFE) has joined up with leaders in the breast cancer community to expand the breast cancer dialogue to include metastatic breast cancer. More